JESSICA ANGELA PAPPANIKOU
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MIAMI, FL NPI 1033720339
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL Stemline Therapeutics Inc. All categories
General Payments — all program years on this page
$1,224.01
- Category: General Payments
- Program years: PY2021–2024
- Record count: 21
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $509.68 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $509.68 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Stemline Therapeutics Inc. | $168.36 | 2 |
| GENZYME CORPORATION | $123.95 | 1 |
| Acerta Pharma LLC | $121.87 | 1 |
| SOBI, INC | $28.62 | 1 |
| Adaptive Biotechnologies Corporation | $25.26 | 1 |
| JAZZ PHARMACEUTICALS INC. | $21.62 | 1 |
| Janssen Biotech, Inc. | $20.00 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078447496 | Janssen Biotech, Inc. | $20.00 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105698708 | AstraZeneca Pharmaceuticals LP | $121.87 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139812801 | GENZYME CORPORATION | $123.95 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141432623 | SOBI, INC | $28.62 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142968171 | Stemline Therapeutics Inc. | $43.62 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142968173 | Stemline Therapeutics Inc. | $124.74 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150265289 | Adaptive Biotechnologies Corporation | $25.26 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151293763 | JAZZ PHARMACEUTICALS INC. | $21.62 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.